2009Chongqing yixueRequires access

Effect of lamirudine in treatment of hepatitis B and liver cirrhosis ascites

Xiaoying Yuan

Open publisher page 0 citations

Abstract

Objective To observe the clinical effect of lamivudine in the treatment of hepatitis B and liver cirrhosis ascites.Methods Eighty-two patients with hepatitis B and liver cirrhosis diagnosed during Jan.2006 to Jan.2007 were divided into treatment group(39 cases)and control group(43 cases).The control group received the routine colligation therapy and the treatment group received lamivudine on the base of routine colligation therapy.Change of hepatic function(ALT,TB,ALB,PTA)and liver fibrosis marker amelioration and ascites extinction effect were observed.Results Compared with control group,the hepatic function of treatment group was improved(P0.05)and ascites was improved too(χ2=9.17,P0.01).Conclusion Lamivudine can improve hepatic function,reduce liver fibrosis marker and accelerate ascites extinction.

About this research paper

What this paper is about

Objective To observe the clinical effect of lamivudine in the treatment of hepatitis B and liver cirrhosis ascites.Methods Eighty-two patients with hepatitis B and liver cirrhosis diagnosed during Jan.2006 to Jan.2007 were divided into treatment group(39 cases)and control group(43 cases).The control group received the routine colligation therapy and the treatment group received lamivudine on the base of routine colligation therapy.Change of hepatic function(ALT,TB,ALB,PTA)and liver fibrosis marker amelioration and ascites extinction effect were observed.Results Compared with control group,the hepatic function of treatment group was improved(P0.05)and ascites was improved too(χ2=9.17,P0.01).Conclusion Lamivudine can improve hepatic function,reduce liver fibrosis marker and accelerate ascites extinction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effect of lamivudine in the treatment of hepatitis B and liver cirrhosis ascites.Methods Eighty-two patients with hepatitis B and liver cirrhosis diagnosed during Jan.2006 to Jan.2007 were divided into treatment group(39 cases)and control group(43 cases).The control group received the routine colligation therapy and the treatment group received lamivudine on the base of routine colligation therapy.Change of hepatic function(ALT,TB,ALB,PTA)and liver fibrosis marker amelioration and ascites extinction effect were observed.Results Compared with control group,the hepatic function of treatment group was improved(P0.05)and ascites was improved too(χ2=9.17,P0.01).Conclusion Lamivudine can improve hepatic function,reduce liver fibrosis marker and accelerate ascites extinction.

Key concepts: Ascites, Cirrhosis, Medicine, Gastroenterology, Lamivudine, Liver function, Internal medicine, Hepatic fibrosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of lamirudine in treatment of hepatitis B and liver cirrhosis ascites — Research Paper | ScholarLens